Refusing puberty blockers to trans young people is not justified by the evidence

Damien W. Riggs, Michelle Tollit, Ashleigh Lin

Research output: Contribution to journalLetterpeer-review

Abstract

We read with interest the Correspondences from Stella O’Malley and colleagues1 and Richard Armitage2 on the use of puberty blockers for transgender and gender diverse (trans) young people, and wish to address several of their comments, which we view as problematic.
Original languageEnglish
Pages (from-to)e35-e36
Number of pages2
JournalThe Lancet Child and Adolescent Health
Volume5
Issue number9
DOIs
Publication statusPublished - Sep 2021

Keywords

  • trans young people
  • puberty blockers
  • Adolescent Health

Fingerprint

Dive into the research topics of 'Refusing puberty blockers to trans young people is not justified by the evidence'. Together they form a unique fingerprint.

Cite this